Improving detection of early-stage metastatic melanoma using advanced microscopy
Improving Accuracy of Next-Generation Microscopy for Early Stage Metastatic Melanoma Detection
This study is testing a new imaging technique to help doctors better identify early-stage melanomas that have spread, so patients can get the right treatment sooner and improve their chances of recovery.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11011335 on NIH RePORTER |
What this research studies
This research investigates a new microscopy technique called femtosecond pump-probe microscopy to accurately identify early-stage melanomas that are actually metastatic. Current methods can misclassify these tumors, delaying necessary treatment and increasing mortality rates. By using this advanced imaging approach, the research aims to better determine which patients with early-stage melanoma may benefit from early adjuvant therapies, potentially improving outcomes and reducing treatment-related side effects. The goal is to establish a reliable method for identifying patients who need immediate intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage melanoma who may actually have undetected metastatic disease.
Not a fit: Patients with confirmed non-metastatic melanoma or those at advanced stages of melanoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more effective treatment for patients with metastatic melanoma, improving survival rates.
How similar studies have performed: Preliminary data suggests that this novel microscopy approach has shown promise, indicating potential success in improving melanoma detection, although it is a relatively new and untested method.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Warren, Warren S — Duke University
- Study coordinator: Warren, Warren S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.